Kevin P. Malobisky
Chief Operations Officer
Kevin P. Malobisky serves as Chief Operations Officer and is a member of DBV’s Executive Committee, responsible for the Company’s Technical Operations, Manufacturing, and global Quality. Dr. Malobisky has 35 years of experience in pharmaceutical and biotechnology research, drug development, and strategic and operational leadership, with a proven track record of success in regulatory affairs, quality & compliance, pharmacovigilance, and pharmaceutical operations. Prior to joining DBV in January 2024, Dr. Malobisky was the Founder and President of KPM Consulting, LLC, co-founder and Chief Regulatory & Quality Officer at Revelar Biotherapeutics, and Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics. Dr. Malobisky previously held senior roles of responsibility in Regulatory Affairs, Quality, and Compliance at Achillion Pharmaceuticals, Karyopharm Therapeutics, Zafgen, Sanofi, and Roche.
Dr. Malobisky earned his B.S. in microbiology from Penn State University, his M.S. in Quality Assurance and Regulatory Affairs from Temple University School of Pharmacy, and his Ph.D. in Organization and Management from Capella University School of Business and Technology, where he graduated with distinction. Dr. Malobisky also holds a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society.